Resources | Pharmaceutical Industry
Top 3 Pharmaceutical Companies
Pfizer Inc.
2010 Revenues: $67.8 billion
2008 Election cycle political contributions
by Pfizer Inc. PAC: $1,236,405
2010 Election cycle: $1,100,814
2010 Lobbying expenditures: $13,330,000
GlaxoSmithKline Plc
2009 Revenues: $28.4 billion
2008 Election cycle political contributions
by GlaxoSmithKline PAC: $793,420
2010 Election cycle: $606,000
2007 Lobbying expenditures: $6,070,000
Sanofi-Aventis (and Subsidiary Sanofi Pasteur)
2009 Revenues: $29.3 billion
2008 Election cycle political contributions
by Sanofi-Aventis PAC: $105,500
2010 Election cycle: $87,000
2007 Lobbying expenditures: $7,573,000
Industry Spending on Lobbying: Overview
- Pharmaceuticals/health products industry PAC
Contributions to 2010 Federal
Candidates: $15,106,423 - The pharmaceutical industry spends more on lobbying
than any other industry. Total lobbying spending
for pharmaceuticals/health products in 2010 was
$240,385,934.
(SOURCE: The Center for Responsive Politics)
INDUSTRY ALLIES
Pharmaceutical Research and Manufacturers of America (PHRMA)
GOVERNMENT/REGULATORY AGENCIES
Food and Drug Administration
NATIONAL RESOURCES
Organizations and Campaigns Challenging Industry Practices
AIDS Treatment Activists Coalition (ATAC)
Center for Media and Democracy/SourceWatch
The Center for Public Integrity
Center for Science in the Public Interest
Commercial Alert
Community Catalyst
Prescription Access Litigation (PAL)
The Prescription Project
Consumers Union
No Free Lunch
PharmedOut
Public Citizen: Health Research Group
INTERNATIONAL RESOURCES
Organizations and Campaigns Challenging Industry Practices
CorpWatch
Essential Action: Access to Medicine Project
Global Exchange
Healthy Skepticism
Multinational Monitor
Selected References on Pharmaceutical Industry Practices and Health
Practices of Corporations in the Pharmaceutical Industry and Health
This list of references is based on a literature review conducted in 2006 and 2007 by Corporations and Health Watch staff. We invite readers to send us additional references.
View the Corporations and Health Archives for more information on the Pharmaceutical Industry.
